+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prezista"

HIV Drugs and Injectables Market Report 2024-2034 - Product Thumbnail Image

HIV Drugs and Injectables Market Report 2024-2034

  • Report
  • July 2024
  • 288 Pages
  • Global
From
Prezista - API Insight, 2022 - Product Thumbnail Image

Prezista - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Prezista is a medication used to treat HIV and hepatitis C infections. It is a protease inhibitor, meaning it works by blocking the action of a specific enzyme that is needed for the virus to replicate. Prezista is used in combination with other antiretroviral drugs to treat HIV infection and is also used to treat chronic hepatitis C infection. It is typically prescribed to patients who have not responded to other treatments or who have developed resistance to other medications. Prezista is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Other companies in the market include Gilead Sciences, AbbVie, Bristol-Myers Squibb, and Merck & Co. Show Less Read more